These findings are consistent with a previous study on patients with gastric cancer, which found that the frequencies of CD3+, CD3+/CD4+, and CD3+/CD8+ T cells expressing CD200R1 were lower in the peripheral blood of patients with gastric cancer than that in the healthy control patients [21]. This evidence concerns the gene CD8A and gastric cancer.